IHL
BMY.RT

Investment House LLC’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Investment House LLC’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16,539
Closed -$11K – 238
2020
Q4 		$11K Hold
16,539
– – ﹤0.01% 219
2020
Q3 		$37K Hold
16,539
– – ﹤0.01% 203
2020
Q2 		$59K Hold
16,539
– – 0.01% 188
2020
Q1 		$63K Sell
16,539
-400
-2% -$1.32K 0.01% 168
2019
Q4 		$51K Buy
+16,939
New +$44K ﹤0.01% 221

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Investment House LLC's BMY.RT Position: Q1 2021 in Review

Investment House LLC sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 16,539 shares — an estimated $11K sold.

Investment House LLC first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $63K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Investment House LLC reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Investment House LLC sold 16,539 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $11K.
  • Investment House LLC first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Investment House LLC's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $63K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Investment House LLC's 13F filing for Q1 2021, filed 6 May 2021.